| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3,6 M € | -4.5% | 3,8 M € | +1.5% | 3,8 M € | -9.6% | 4,2 M € | -13.8% | 4,8 M € | -3.2% | 5,0 M € | -15.8% | 5,9 M € | -13.0% | 6,8 M € | +6.7% | 6,4 M € | +5.0% | 6,1 M € | +16.9% | 5,2 M € | -13.3% | 6,0 M € | -4.6% | 6,3 M € | -14.3% | 7,3 M € | +19.5% | 6,1 M € | -34.1% | 9,3 M € | -3.0% | 9,6 M € | -6.3% | 10,2 M € | |
| EBITDA | 181,8 k € | +60.5% | 113,2 k € | +150.7% | 45,2 k € | -62.8% | 121,5 k € | +2.2% | 118,9 k € | +1.2% | 117,5 k € | +10.7% | 106,1 k € | -23.7% | 139,0 k € | -16.5% | 166,5 k € | +50.9% | 110,4 k € | -37.0% | 175,2 k € | -2.7% | 180,0 k € | -14.1% | 209,4 k € | -11.9% | 237,6 k € | +321.2% | 56,4 k € | -92.5% | 750,8 k € | -43.7% | 1,3 M € | -45.3% | 2,4 M € | |
| Operating profit | 161,3 k € | +102.1% | 79,8 k € | +86.3% | 42,8 k € | -63.6% | 117,6 k € | +3.0% | 114,1 k € | +2.1% | 111,8 k € | -8.4% | 122,0 k € | -7.8% | 132,3 k € | +86.8% | 70,8 k € | -41.5% | 121,0 k € | -7.3% | 130,5 k € | -41.4% | 222,8 k € | +0.4% | 221,9 k € | -17.4% | 268,5 k € | +23.1% | 218,1 k € | -69.2% | 707,8 k € | -47.2% | 1,3 M € | -39.0% | 2,2 M € | |
| Profit/loss | 619,9 k € | +1149.7% | 49,6 k € | +147.4% | 20,0 k € | -96.5% | 579,7 k € | +25.7% | 461,1 k € | -21.0% | 583,6 k € | -12.8% | 669,5 k € | -13.4% | 773,1 k € | +25.4% | 616,6 k € | -35.0% | 948,5 k € | +5.8% | 896,3 k € | -10.0% | 995,4 k € | -11.9% | 1,1 M € | -4.0% | 1,2 M € | +511.2% | 192,5 k € | -90.5% | 2,0 M € | -59.3% | 5,0 M € | +68.0% | 3,0 M € | |
| Equity | 3,1 M € | 0.0% | 3,1 M € | 0.0% | 3,1 M € | 0.0% | 3,1 M € | -18.7% | 3,8 M € | 0.0% | 3,8 M € | 0.0% | 3,8 M € | 0.0% | 3,8 M € | -78.5% | 17,5 M € | +3.7% | 16,9 M € | +6.0% | 15,9 M € | +6.0% | 15,0 M € | +7.1% | 14,0 M € | +8.8% | 12,9 M € | +23.1% | 10,5 M € | 0.0% | 10,5 M € | 0.0% | 10,5 M € | +50.3% | 7,0 M € | |
| Total assets | 4,4 M € | +13.2% | 3,9 M € | +1.7% | 3,9 M € | -27.5% | 5,3 M € | -5.2% | 5,6 M € | +9.0% | 5,2 M € | -11.1% | 5,8 M € | -25.0% | 7,7 M € | -58.7% | 18,7 M € | +5.3% | 17,8 M € | +4.2% | 17,1 M € | +0.0% | 17,1 M € | +12.6% | 15,1 M € | +8.3% | 14,0 M € | +15.7% | 12,1 M € | -17.6% | 14,7 M € | +6.2% | 13,8 M € | +22.7% | 11,3 M € | |
| Cash | 63,7 k € | -17.6% | 77,3 k € | +140.8% | 32,1 k € | +31.0% | 24,5 k € | -50.3% | 49,3 k € | -59.3% | 121,1 k € | -27.2% | 166,4 k € | -52.5% | 350,7 k € | +61.4% | 217,2 k € | +91.8% | 113,2 k € | +78.7% | 63,4 k € | +2.6% | 61,8 k € | +25.8% | 49,1 k € | -28.8% | 69,0 k € | -78.3% | 317,4 k € | +89.5% | 167,5 k € | +7.6% | 155,6 k € | -30.0% | 222,4 k € | |
| Debts | 1,4 M € | +77.5% | 788,2 k € | +7.7% | 731,8 k € | -67.9% | 2,3 M € | +21.6% | 1,9 M € | +32.8% | 1,4 M € | -31.3% | 2,1 M € | -48.5% | 4,0 M € | +220.7% | 1,2 M € | +34.3% | 925,0 k € | -20.2% | 1,2 M € | -43.4% | 2,0 M € | +81.6% | 1,1 M € | +2.3% | 1,1 M € | -32.0% | 1,6 M € | -61.4% | 4,2 M € | +25.6% | 3,3 M € | -21.9% | 4,3 M € | |
| Staff | 5 | 5 | 5 | 5 | 5 | 5,7 | 5,4 | 1,9 | 2,9 | 2,9 | 2,9 | 3,4 | 4,8 | 4,9 | 5 | 6 | 5 | 5,7 | ||||||||||||||||||
Private limited company · Mouscron · incorporated on 28/09/1992 · 5,0 ETP
Private limited company profitable and well capitalised. Cash position declining (-17.6%).
Solid counterparty for a standard engagement.
MACO - PHARMA BENELUX is a Private limited company incorporated in 1992. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Mouscron. It employs on average 5,0 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette